KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dayforce (DAY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Dayforce (DAY) over the last 10 years, with Q3 2025 value amounting to $2.6 billion.

  • Dayforce's Cash & Equivalents rose 825.34% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 825.34%. This contributed to the annual value of $2.3 billion for FY2024, which is 684.02% up from last year.
  • According to the latest figures from Q3 2025, Dayforce's Cash & Equivalents is $2.6 billion, which was up 825.34% from $2.5 billion recorded in Q2 2025.
  • Over the past 5 years, Dayforce's Cash & Equivalents peaked at $2.6 billion during Q3 2025, and registered a low of $339.6 million during Q1 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $2.0 billion (2022), whereas its average is $2.0 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 93740.7% in 2021, then crashed by 337.85% in 2023.
  • Quarter analysis of 5 years shows Dayforce's Cash & Equivalents stood at $2.0 billion in 2021, then rose by 3.0% to $2.0 billion in 2022, then grew by 8.32% to $2.2 billion in 2023, then grew by 6.84% to $2.3 billion in 2024, then grew by 12.44% to $2.6 billion in 2025.
  • Its Cash & Equivalents was $2.6 billion in Q3 2025, compared to $2.5 billion in Q2 2025 and $2.4 billion in Q1 2025.